A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment

NCT06400511 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

477

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Blepharitis

Interventions

DRUG: Pimecrolimus 0.3% Ophthalmic Ointment
DRUG: Placebo Ophthalmic Ointment

Sponsor

Famy Life Sciences, a Viatris Company